Virtu Financial’s Co-Diagnostics CODX Stock Holding History

Virtu Financial’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$55K	Buy	+17,612	New	+$54.2K	﹤0.01%	1209
2025 Q4	–	Sell	-4,217	Closed	-$44K	–	1755
2025 Q3	$44K	Buy	4,217 +3,363	+394%	+$31.3K	﹤0.01%	1152
2025 Q2	$7K	Sell	854 -954	-53%	-$8.92K	﹤0.01%	1337
2025 Q1	$17K	Buy	+1,808	New	+$34.6K	﹤0.01%	1122
2024 Q4	–	Sell	-368	Closed	-$14K	–	1616
2024 Q3	$14K	Sell	368 -562	-60%	-$21.6K	﹤0.01%	1159
2024 Q2	$35K	Buy	+930	New	+$33.8K	﹤0.01%	952
2023 Q2	–	Sell	-525	Closed	-$23K	–	1593
2023 Q1	$23K	Sell	525 -2	-0.4%	-$160	﹤0.01%	1221
2022 Q4	$40K	Buy	+527	New	+$49.3K	0.01%	1119
2021 Q2	–	Sell	-1,660	Closed	-$475K	–	1583
2021 Q1	$475K	Buy	1,660 +795	+92%	+$317K	0.03%	543
2020 Q4	$241K	Buy	+865	New	+$320K	0.03%	758
2020 Q3	–	Sell	-2,286	Closed	-$1.33M	–	1131
2020 Q2	$1.33M	Buy	+2,286	New	+$1.04M	0.15%	143
2019 Q4	$34K	Buy	+1,250	New	+$36.9K	﹤0.01%	1261

Other funds holding CODX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PAG

Private Advisory Group Redmond, Washington $1.85B AUM 50.66% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Virtu Financial's CODX Position: Q2 2026 in Review

Virtu Financial opened a new position in Co-Diagnostics (CODX) in Q2 2026: 17,612 shares worth $55K. The stake represents ﹤0.01% of the portfolio and ranks #1209 among its holdings. This is a return to the name: Virtu Financial previously reported a position in CODX as recently as Q3 2025.

Virtu Financial first reported a position in CODX in Q4 2019 and has held it in 12 quarters since. The position peaked at $1.33M in Q2 2020. 24 funds tracked by Wall St. Rank hold CODX as of Q2 2026.

Virtu Financial held 17,612 shares of Co-Diagnostics worth $55K as of Q2 2026.
Co-Diagnostics was a new Virtu Financial position in Q2 2026.
Co-Diagnostics made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1209 holding.
Virtu Financial first reported a position in Co-Diagnostics in Q4 2019 and has held it in 12 quarters since.
Virtu Financial's Co-Diagnostics position peaked at $1.33M in Q2 2020.
24 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.